Stockreport

GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH [Yahoo! Finance]

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the inclusion of NIS2+® as a key to [Read more]